Artelo Biosciences
ARTL • NASDAQ
Artelo Biosciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Gregory D. Gorgas, with a market cap of $7.8M.
Market Cap$7.8M
Employees6.0
CEOGregory D. Gorgas
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
Artelo Biosciences FAQ
Common questions about Artelo Biosciences
Artelo Biosciences is scheduled to report earnings for Q1 2026 on May 12, 2026.
Artelo Biosciences has approximately 6 employees.